Huajian Medical, a Hong Kong-listed company, has established a wholly-owned subsidiary, IVD GROUP, in New York State. This new entity will spearhead the company's IVDNewCo Exchange strategy in the United States. In a significant move towards expanding its operations, the subsidiary has begun the process of applying for a stablecoin license with US regulatory bodies, including the SEC and CFTC. This development marks a key step in Huajian Medical's strategy to enhance its global compliance and operational footprint.